Blincyto האיחוד האירופי - נורבגית - EMA (European Medicines Agency)

blincyto

amgen europe b.v. - blinatumomab - forløpercellelymfoblastisk leukemi-lymfom - antineoplastiske midler - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.

Dalacin 15 mg/ ml נורווגיה - נורבגית - Statens legemiddelverk

dalacin 15 mg/ ml

pfizer as - klindamycinpalmitathydroklorid - granulat til mikstur, oppløsning - 15 mg/ ml

Dalacin 150 mg נורווגיה - נורבגית - Statens legemiddelverk

dalacin 150 mg

pfizer as - klindamycinhydroklorid - kapsel, hard - 150 mg

Dalacin 300 mg נורווגיה - נורבגית - Statens legemiddelverk

dalacin 300 mg

pfizer as - klindamycinhydroklorid - kapsel, hard - 300 mg

Palladia האיחוד האירופי - נורבגית - EMA (European Medicines Agency)

palladia

zoetis belgium sa - toceranib - antineoplastiske midler - hunder - behandling av ikke-resekterbare patnaik grade ii (mellomstore) eller -iii (høyverdige), tilbakevendende, kutane mastcelletumorer hos hunder.

Dalacin 150 mg/ ml נורווגיה - נורבגית - Statens legemiddelverk

dalacin 150 mg/ ml

pfizer as - klindamycinfosfat - injeksjonsvæske, oppløsning - 150 mg/ ml

Dalacin 10 mg/ ml נורווגיה - נורבגית - Statens legemiddelverk

dalacin 10 mg/ ml

pfizer as - klindamycinfosfat - liniment, emulsjon - 10 mg/ ml

Dalacin 2 % נורווגיה - נורבגית - Statens legemiddelverk

dalacin 2 %

pfizer as - klindamycinfosfat - vaginalkrem - 2 %

Dalacin 100 mg נורווגיה - נורבגית - Statens legemiddelverk

dalacin 100 mg

pfizer as - klindamycinfosfat - vagitorie - 100 mg

Palladon 50 mg/ ml נורווגיה - נורבגית - Statens legemiddelverk

palladon 50 mg/ ml

mundipharma as - hydromorfonhydroklorid - injeksjons-/infusjonsvæske, oppløsning - 50 mg/ ml